US Enteric Disease Testing Market Market Report 2023 to 2030

US Enteric Disease Testing Market Analysis

$ 3999

US Enteric Disease Testing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Enteric Disease Testing is expanding as a result of the increasing incidence of enteric diseases in both developed and developing nations. This demand is fueling the development of better devices and methods for the early detection and accurate diagnosis of Enteric diseases. Some of the key players in the global Enteric Disease Testing Market include Alere Inc.; Becton, Dickinson & Company; Biomerica Inc.; bioMerieux; Bio-Rad Laboratories; Cepheid; Coris BioConcept; DiaSorin; Meridian BioSceinces; and Quest Diagnostics.

ID: IN10USHS047 CATEGORY: Healthcare Services GEOGRAPHY: US AUTHOR: Dr. Nensi Savani

Buy Now

US Enteric Disease Testing Market Executive Summary

US Enteric Disease Testing Market is valued at around $1.49 Bn in 2022 and is projected to reach $1.55 Bn by 2030, exhibiting a CAGR of 0.5% during the forecast period 2023-2030.

The Enteric Disease Testing Market refers to the market for tests and methods used to diagnose enteric disease, a type of intestinal disease that is caused by different microorganisms such as parasites, viruses, and bacteria. The market includes software and platforms for analyzing and interpreting the findings of diagnostic tests, which are used to detect the disease.

The increasing Prevalence of enteric diseases and investment in research and development has contributed to the growth of the global enteric disease market in recent years. Advancements in technologies like molecular diagnostics and point-of-care testing are also driving the global market for enteric disease testing.

There are many global players in the enteric disease testing market but Alere Inc.; Becton, Dickinson & Company; Biomerica Inc.; bioMerieux; Bio-Rad Laboratories; Cepheid; Coris BioConcept; DiaSorin; Meridian BioSceinces; and Quest Diagnostics. Are some of the major players in the market.

Enteric Disease can be diagnosed using a variety of methods and tests, including serological tests, antigen detection tests, blood tests, stool cultures, and Enzyme Immunoassays. Advanced methods like Microbiome analysis and advanced multiplex assays are being researched and developed for enteric disease testing.

The increasing prevalence of enteric diseases, increasing healthcare expenditure, advancement in technology for testing, and rising knowledge are projected to fuel the market for enteric disease testing in the coming years. The market still has many difficulties like complex regulatory procedures, antimicrobial resistance, limitation of resources, and emerging pathogens. All of these factors are likely to affect the growth of the market.

Market Dynamics

Drivers of US Enteric Disease Testing Market:

Growing Prevalence of Enteric Disease: The prevalence of enteric diseases is increasing with every passing year. Enteric diseases like gastroenteritis, foodborne illnesses, and diarrheal diseases are most common among others. This is raising the demand for diagnostic methods and technologies that can successfully identify the illness.

Advancement in Technologies: Molecular diagnostic techniques like PCR and next-generation sequencing have increased the efficiency and accuracy of diagnostic kits for enteric diseases. They provide rapid and precise identification of microorganisms; it has driven the market for enteric disease testing.

Increasing Healthcare Expenditure: The market for enteric disease testing is expanding as a result of rising healthcare spending in both developed and developing nations. This demand is fueling the development of better diagnostic tests and methods for the early detection and accurate diagnosis of enteric disease.

Point-of-Care Testing: Demand for point-of-care testing is increasing in remote areas where healthcare facilities are not sufficiently available and resources are limited. With point-of-care testing, there is no need for laboratory infrastructure set up and it gives immediate results which helps in rapid decision-making. It is driving the global market for enteric disease.

Developments in Enteric Disease Testing Market:

The market for enteric disease diagnostics is always changing due to new discoveries and improvements in science and technology. Recent market developments include the following:

Advancements in Next-Generation Sequencing: NGS gives a comprehensive analysis of genomes, facilitating strain type, resistance profile, and other epidemiological investigations. It has enhanced the capability of enteric disease testing

AI-Powered Diagnostics: AI algorithms and machine learning techniques are integrated with enteric disease testing and it has improved analysis, interpretation, and decision-making. Compared to conventional techniques, these instruments offer more effective and precise diagnoses for enteric disease.

Rapid Antigen Tests: These tests provide quick results and can be performed at any place and no healthcare infrastructure is needed to perform these tests. It helps in quick decision-making and timely initiation of the treatment. The growth of rapid antigen tests was boosted during the Covid-19 pandemic and it has boosted the market for enteric disease testing as well.

Given that they increase the precision and accessibility of diagnostic tools and techniques for Enteric disease, these innovations are anticipated to propel the expansion of the market for Enteric Disease Testing.

Key players

Abbott Laboratories Bio-Rad Laboratories, Inc. bioM?rieux SA Becton, Dickinson and Company (BD) Thermo Fisher Scientific, Inc. QIAGEN N.V. Roche Diagnostics Luminex Corporation Meridian Bioscience, Inc. Hologic, Inc.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Market Segmentations For US Enteric Disease Testing Market

By Pathogen:

E coli
Salmonella
Campylobacter
Listeria
Other pathogens

By Technology:

Traditional
Rapid
Convenience-based
Polymerase chain reaction (PCR)
Immunoassay
Chromatography & spectrometry

By End-Use:

Water
Food
- Meat, Poultry, and Seafood
- Dairy Products
- Processed Food
- Fruits & Vegetables
Other

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.